Study of the Safety and Tolerability of IV Infused PG545 in Patients With Advanced Solid Tumours
NCT02042781
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
23
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumours
Interventions
DRUG:
PG545
Sponsor
Zucero Pty Ltd